Lysophosphatidic acid (LPA) is a naturally occurring phospholipid with growth-factor-like activities [van Corven, Groenink, Jalink, Eichholtz & Moolenaar (1989) 
INTRODUCTION
Among the great variety of cellular lipids, PA and LPA are the focus of increasing attention. Apart from their precursor role in lipid biosynthesis de novo [1] , these simple phospholipids are produced rapidly in activated cells (see, e.g., [2] [3] [4] [5] ), suggesting a potential role as intracellular second messenger. Furthermore, they can stimulate DNA synthesis and cell division when added extracellularly to fibroblasts or epithelial cells in culture [6] [7] [8] [9] [10] .
Our recent studies suggest that LPA acts, at least in part, by activating a subset of the family of membrane-bound G-proteins, including the inhibitory G-protein (Ga) of adenylate cyclase and the stimulatory G-protein of phosphoinositide-specific phospholipase C [8, 11, 12] . We also presented evidence suggesting that previously reported Ca2+-mobilizing effects of PA are actually due to LPA [11] , a common contaminant of commercially available PA. However, the latter result does not necessarily imply that the long-term mitogenic effect of PA is similarly due to contaminating lyso-derivatives.
In the present study we have prepared LPA analogues with varying acyl-chain composition to establish the relationship between specific structural features of the LPA molecule and its mitogenic activity in quiescent fibroblasts. Insight into the structure-activity relationship should help to clarify further the mechanism of action of extracellularly added LPA, to solve the PA-LPA contamination problem, and also to discover potential LPA antagonists. Our For measurements of DNA content, quiescent cells in six-well tissue-culture dishes were trypsin-treated, suspended in PBS and fixed in 70 % (v/v) ethanol. After fixation the cells were kept on ice for at least 3 h. Cells were then centrifuged (200 g for 5 min), ethanol was removed and I ml of RNAase A (0.5 mg/ml) dissolved in 100 mM-NaCl/100 mM-Tris (pH 7.5) was added. After incubation for 30 min at 37°C, 1 ml of pepsin (2500 FIP U/g; 1 mg/ml) in 0.4% HCI was added and incubation was continued for another 45 min. Next, 2 ml of ethidium bromide (20 #tg/ml) and Hoechst dye H33258 (8 ,ug/ml) in 200 mM-Tris (pH 8-8.5) and 0.5 % BSA were added, and after a 15 min incubation period at room temperature, cells were centrifuged at 500 g for 10 min. The pellet was resuspended in 300 ,ul of ethidium bromide/Hoechst dye solution and cell-cycle parameters were analysed with a fluorescence-activated cell sorter.
Preparation of LPAs
LPAs with various chain lengths were prepared enzymically either from the corresponding lysophosphatidylcholines by using phospholipase D, or from commercially available PA by using phospholipase A2, essentially as described by Kates [13] . When the phospholipase D method was used, 5 mg of lysophosphatidylcholine (l-oleoyl, I-palmitoyl, 1-myristoyl, I-lauroyl, or 1-decanoyl) was added to 1 ml of 100 mM-potassium acetate (pH 5.6) and 10 mM-CaCl2, followed by bath sonication. Phospholipase D (3-6 mg; 640 units/mg of protein) was then added and the reaction mixture was kept under N2 at room temperature for 12-16 h. Phospholipids were extracted with 5 ml of chloroform/methanol (1: 1, v/v) and 1.25 ml of 100 mM-HCl. The chloroform phase was evaporated and analysed by t.l.c. in the solvent system chloroform/methanol/water/acetic acid (50:30:4:2, by vol.) (in this system the R. values for the longchain lysophosphatidylcholine, LPA and PA are 0.09, 0.37 and 0.59 respectively; the shortest-chain-length LPA and PA tested, decanoyl, has a 15 % lower RF value). LPAs were detected by water spraying, scraped into vials and extracted with three subsequent washes with the chloroform/methanol/HCI solution.
LPAs were quantified by the phosphate-content assay of Morrison [14] .
In the phospholipase A2 method, 5 mg of PA (dioleoyl, dipalmitoyl, dimyristoyl, dilauroyl or didecanoyl) was dissolved in 1 The fatty acyl composition of LPA was determined by g.l.c. after trans-esterification with dry methanolic 0.2 M-NaOH for 90 min at 50 'C. After neutralization with acetic acid, the fatty acid methyl esters were extracted with chloroform, evaporated under nitrogen and taken up in n-hexane; [1] [2] [3] [4] [5] ,tg of lipid was used for each analysis.
Depending on the supplier, 1-oleoyl LPA was found to contain more than 99 % oleate, and minor traces of palmitate, myristate and laurate (Sigma). 1-Myristoyl LPA contained approx. 97 % myristate and 0.2 % lipid material co-migrating with an oleate marker, and 0.3 % co-migrating with a palmitate marker. After h.p.l.c. purification, both 1-oleoyl and 1-myristoyl LPA induced the same mitogenic response as non-h.p.l.c.-purified samples. Although it cannot be rigorously excluded that some of the 1-acyl LPA undergoes acyl migration to yield 2-acyl LPA during prolonged incubation at 37 'C, the potential for acyl migration of 1-acyl glycerol is known to be very low under normal assay conditions [15] .
Inositol phosphates
Confluent cells in six-well tissue-culture dishes were labelled for 48 h to near isotopic equilibrium with 2 ,Ci of myo-[3H]inositol/ml in DMEM containing 0.1 % FCS. At 2 h before stimulation the cells were shifted to serum-free DMEM containing 20 mM-Hepes (pH 7.5). Cells were stimulated with agonist for 30 min in the presence of 10 mM-LiCI, and the reactions were stopped with ice-cold 10% (w/v) trichloroacetic acid. After extraction of the supernatant with diethyl ether, samples were processed for analysis of total [3H]inositol phosphates as described by Tilly et al. [16] .
RESULTS
Growth-factor-like action of LPA and effect of acyl-chain length Table 1 shows the relative mitogenic properties of I-oleoyl LPA in the presence and absence of insulin (5 ,ug/ml), as compared with various other mitogens (FCS, EGF, peptide hormones) in both Rat-I and Swiss 3T3 cells. It appears that there is little or no synergism between LPA and insulin, contrary to the prominent synergistic effects observed between EGF and insulin or bombesin and insulin in Swiss 3T3 cells. In this cell type, a saturating concentration of LPA alone is about equally potent as the synergistic combination of EGF with insulin or bombesin with insulin (Table 1) .
To examine how the acyl-chain length at the sn-I position of the glycerol backbone affects mitogenic potency, LPA analogues containing various fatty acid moieties were prepared and tested for their ability to stimulate DNA synthesis in quiescent fibroblasts. Fig. 1(a) shows the mitogenic dose-response relationships of various l-acyl LPAs for serum-deprived Rat-I cells. Effects of ether-linked LPA and hexadecyl phosphate A small proportion of naturally occurring phospholipids are ether (alkyl) derivatives, i.e. the fatty acid in the sn-I position is linked to the glycerol moiety by an ether rather than an ester bond [17] . We compared the mitogenic potency of 1-O-hexadecylglycerol 3-phosphate with that of I-palmitoyl LPA in Rat-I cells. This particular ether analogue of LPA is of interest, since it has been reported to be considerably more potent in promoting platelet aggregation than the corresponding 1-acylated compound [18] . As summarized in Table 2 (Table 2) . From these data it appears that an ester-linked long-chain fatty acid and a glycerol backbone are essential for mitogenic activity of LPA.
Mitogenic effects of phosphatidic acids
To evaluate the mitogenic effects of the 1,2-diacyl form (PA), we tested various PA derivatives. Their relative potencies in evoking DNA synthesis are summarized in Table 3 , and the dose-response curve for 1,2-dioleoyl PA is shown in Fig. l(b) . Again, decreasing the acyl chain length at both the sn-I and the sn-2 position leads to a progressive decrease in mitogenic activity. The I-stearoyl 2-arachidonoyl analogue of PA is also a potent inducer of DNA synthesis (Table 3) . Because PA is known to contain contaminating traces of lyso-derivatives [11] , care was taken to use freshly prepared PA solutions in which contamination was always less than approx. 1 % as judged by t.l.c. Since the dose-response curves of I-oleoyl LPA and 1,2-dioleoyl PA for inducing DNA synthesis were found to be very similar (Figs. la and lb), with almost identical threshold concentrations, the observed mitogenic effect ofPA cannot simply be the consequence of LPA contamination. Furthermore, when low doses of LPA (1-10 /IM) were added in the presence of 100 JaM-PA, no potentiating effect on DNA synthesis was observed. Also, addition of Vol. 281 [3HlThymidine incorporation Addition (% of response to l-oleoyl LPA)
LPA (l-oleoyl) (100 /M)
None 100+ 14 (45) 97±6 (12) 83 +16 (41) 90+19 (11) 91±9 (14) 55+9 (14) 35±6 (16) Effect of short-chain LPA on long-chain (L)PA-induced DNA synthesis Given the very weak mitogenic activity of 1-decanoyl (L)PA, we examined these short-chain analogues for possible antagonistic effects on l-oleoyl LPA-and 1,2-dioleoyl PA-induced DNA synthesis. When added at relatively high concentrations (100 LM), the decanoyl analogue showed no detectable inhibition of l-oleoyl LPA-induced DNA synthesis (tested at 1, 10 and 100 /SM in three independent experiments). Similarly, didecanoyl-PA failed to attenuate the mitogenic activity of dioleoyl PA.
Inhibitory effect of suramin on DNA synthesis
The polyanionic naphthalenesulphonic acid derivative suramin is a known inhibitor of growth-factor action. Although its mode ofaction is poorly understood, suramin is membrane-impermeant [19] , and is known to interfere with the interaction between peptide growth factors and their receptors, with differential dosesensitivities [20] [21] [22] [23] [24] [25] . Strikingly, suramin inhibits 1-oleoyl LPA-and 1,2-dioleoyl PA-induced DNA synthesis in Rat-I cells in a dose-dependent manner, as shown in Fig. 4(a) . Half-maximal inhibitory concentrations (IC50) are approx. 0.1 mg of suramin/ml (70 #M), and 80-85 % inhibition is obtained at 1.0 mg/ml (0.7 mM). Suramin does not inhibit EGF-induced DNA synthesis, at least over the concentration range affecting LPA action (Fig. 4a) . This finding is consistent with a previous report that the dose of suramin required to inhibit EGF-induced mitogenicity is much higher than that for other mitogens [23] . The effect of suramin is fully reversible, as inferred from the finding that cells pretreated with I mg of suramin/ml for 24 h, followed by wash-out, show a normal mitogenic response upon subsequent treatment with l-oleoyl LPA (results not shown). Exposure of Rat-I cells to suramin at various times after LPA addition reveals that the drug exerts its inhibitory action in the early G0/Gl-phase of the cell cycle: Fig. 4(b) shows that suramin progressively loses its effect when it is added to the cells at increasingly later time points after LPA. At 6 h after LPA addition, suramin is almost completely ineffective in attenuating LPA action (Fig. 4b) .
Suramin inhibits LPA-induced phosphoinositide hydrolysis We also examined the ability of suramin to inhibit the earliest detectable cellular response to LPA, i.e. the breakdown of phosphoinositides [8, 11] . Exposure of [3H]inositol-labelled cells to 100 /IM-l-oleoyl LPA in the presence of suramin (0.5 mg/ml) results in complete inhibition of inositol phosphate accumulation as measured over a 30 min period ( Table 4) . As a control, suramin fails to affect inositol phosphate production evoked by the peptide endothelin, a highly potent inducer of phosphoinositide hydrolysis in Rat-I cells (Table 4 ; see also [26] ). Together, these results suggest that suramin antagonizes longterm (L)PA mitogenicity by intervening with an early step in the (L)PA-activity pathway, most likely at the level of the plasma membrane.
DISCUSSION
The present studies were undertaken to investigate the structure-activity relationship of LPA-induced DNA synthesis in quiescent fibroblasts and to search for pharmacological antagonists. The structural modifications made involved changes in the hydrophobic fatty acid moiety of the LPA molecule. The results indicate that the naturally occurring long-chain LPAs (C18,l and C16:0) are by far the most potent in inducing DNA synthesis, and that mitogenic activity is progressively decreased with decreasing acyl-chain length; the C10 molecule (decanoyl LPA) is almost completely devoid of biological activity. Our results also indicate that the ester linkage between the fatty acid and the glycerol backbone at the sn-I position is essential for mitogenic activity. Modification of the ester linkage to an ether linkage largely abolishes mitogenic activity and, in fact, turns it into a cytotoxic compound. Ether-linked phospholipids follow metabolic routes that are different from those utilized by esterlinked phospholipids [27] . One possibility is that ether-linked LPA yields metabolic products that interfere with long-term cellular viability in general and stimulation of DNA synthesis in particular.
We found that, on a molar basis, long-chain PAs are about equally potent as the corresponding LPAs, with the mitogenic potency again being correlated with the length of the acyl chains. The concentrations required for stimulation of DNA synthesis are within the 1-100 /UM range. This is in marked contrast with LPA-induced Ca2l mobilization, which is observed at far lower concentrations (10-500 nM; ref. [11] ). Furthermore, PA fails to mimic LPA in the early Ca2+-signalling response, even when added at micromolar concentrations [11] . In fact, previously reported Ca2+-mobilizing effects of PA [6] are most likely due to contaminating lyso-derivatives [11] . Yet the possibility that the mitogenic responses observed with various diacyl PAs (Table 3) are similarly due to contaminating traces of LPA seems highly unlikely. First, when PA was purified by t.l.c. in a system which clearly separates it from LPA, the mitogenic response still persists. Second, a LPA contamination of at most 1 % (as can be observed in commercial PA operations) cannot explain the remarkable similarity of the dose-response curves of LPA and PA. Third, addition of LPA in the presence of saturating amounts of PA does not further increase the magnitude of the mitogenic response. For these reasons, we feel safe to conclude that both LPA and PA have growth-factor-like properties with about equal potencies on a molar basis. The structure-activity data suggest that the degree of partitioning into the plasma-membrane bilayer is a major determinant of the mitogenic potencies of these phospholipids.
In a search for potential antagonists, we first focused on (L)PA analogues possessing the weakest mitogenic activity, i.e. the decanoyl derivatives. Although dilauroyl-PA has been reported to antagonize certain biological activities of long-chain diacylPAs [10, 28] , our results clearly indicate that the short-chain (L)PA analogues lack significant antagonist activity when tested in mitogenic assays. The polysulphonated compound suramin was found to inhibit both LPA-and PA-induced DNA synthesis in a reversible and dose-dependent manner (IC50 170 M). The drug appears to act at an early point in the pre-replicative phase of the cell cycle and inhibits early biochemical responses to LPA, such as phosphoinositide hydrolysis; importantly, suramin does not interfere with cell proliferation and signal transduction in general, as evidenced by the results obtained with EGF and endothelin respectively. Suramin has previously been reported to inhibit growth-factor-receptor interactions, particularly those of platelet-derived growth factor, transforming growth factor-fl and insulin-like growth factor-1 [20] [21] [22] [23] 25] . Suramin also dissociates low-density lipoprotein from its receptor [29] and inhibits P2-purinergic-receptor-mediated signal transduction, presumably at the receptor level [30, 31] . Suramin does not cross cell membranes [19] and, although the drug may be taken up by endocytosis, our results support the view that suramin acts extracellularly rather than intracellularly. Suramin can form complexes with proteins, thereby exerting profound effects on protein tertiary structure, which might explain its liganddisplacing properties [32] . In view of these considerations, our findings obtained with suramin would agree with the hypothesis that (L)PA action is mediated by a specific cell-surface receptor. Caution is needed, however, since polyanionic compounds such as suramin may exert their effects by non-specifically binding to the cell surface. Furthermore, we cannot rule out that suramin may interact with the (L)PA molecule itself, rendering it biologically inactive. In a conventional t.l.c. experiment, however, presence of excess suramin did not interfere with the migration behaviour of 1-oleoyl LPA to any extent (E. J. van Corven, unpublished work).
The 'receptor hypothesis' is, of course, not necessarily incompatible with a 'bilayer partitioning' model to explain (L)PA action. Inserted long-chain (L)PA might diffuse laterally within the plane of the lipid bilayer and then have access to a putative receptor which could recognize the glycerol phosphate moiety or the phosphate head group. Although the identification of a putative LPA 'receptor' awaits further studies, the biochemical mechanisms behind LPA action have been elucidated in some detail [8] . It was reported that LPA-induced DNA synthesis is blocked by pertussis toxin and is thought to be initiated by inhibition of adenylate cyclase and, to a lesser extent, by stimulation of phosphoinositide-specific phospholipases C through G-proteins. Given the similarity between the mitogenic activities of LPA and PA (e.g. acyl-chain-length dependence, dose-response curves, kinetics of entry into S-phase), and in view of their similar sensitivity to pertussis toxin (E. J. van Corven, unpublished work) and suramin, both phospholipids are likely to act through the same signalling pathways, apparently involving (a) pertussis-toxin-sensitive G-protein(s). However, the results obtained to date raise a number of questions to which there are only partial answers as yet. For example: (i) why do cells require much higher concentrations of LPA for DNA synthesis than for evoking early responses (cf. ref. [11] )?; (ii) apart from possible interaction with a putative cell-surface receptor, is uptake and/or metabolic conversion of LPA and PA essential for long-term mitogenicity? (however, the major metabolic breakdown products of LPA and PA (monoacylglycerol and diacylglycerol respectively; [33] , and R. van der Bend, unpublished work} lack any mitogenic activity in our cell system [8] ; (iii) does native endogenously produced (L)PA at the plasma membrane act in a similar manner to exogenously supplied (L)PA to stimulate DNA synthesis? By using (L)PA analogues with nonhydrolysable phosphonate headgroups, together with microinjection studies, these questions can be examined in further detail.
